FeesSafety
Pluang+

Winmark shares fall 22.5% but remain overvalued amid weaker profits and mixed cash flow.

Market News
02 Oct 2026
Seeking Alpha
View Source
Bearish
Winmark shares fall 22.5% but remain overvalued amid weaker profits and mixed cash flow.

Winmark Corporation's stock has dropped 22.5% since May but is still considered overvalued. While the company saw growth in revenue and franchise locations, its profitability declined in the first half of 2026, with lower profits and cash flows compared to last year. Operating cash flow and EBITDA showed mixed results, and increased spending on SG&A to support future growth has pressured current margins. Investors will watch the Q3 2026 earnings report on October 16 for signs of improved profitability or further stock decline to reassess valuation.

Winmark Corporation's stock has dropped 22.5% since May, providing context for readers following this company. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 02, 2026 22:41 WIB: out of 112 priced US stocks, 51 rose and 61 fell. Notable movers include MakeMyTrip Ltd (MMYT) at USD 45.17 with a 1-day change of -5.40%, Tesla, Inc. (TSLA) at USD 373.07 with a 1-day change of +5.35% and a Pluang order activity of 65% Sell / 35% Buy, and Global E Online Ltd (GLBE) at USD 38.66 with a 1-day change of -3.85%.

More News

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, a key infrastructure initiative aimed at strengthening the electricity network's security and resilience in the Balearic Islands. ...

Market News
Bullish
19 minutes ago
Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche reported a 7% sales increase at constant exchange rates in Q3 2026, with a 6% rise for the first nine months, fueled by high demand for key medicines like Xolair, Hemlibra, and Ocrevus. The Pharmaceuticals Division led growth, while Diagnostics...

Company Fundamentals
Bullish
19 minutes ago
Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen reported a 24.6% sales growth at constant exchange rates for the first nine months of 2026, driven by strong performance in Oncology, Rare Disease, and Neuroscience segments. The company upgraded its full-year sales growth guidance to around 23...

Company Fundamentals
Bullish
19 minutes ago
Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, aimed at enhancing the electricity network's security and resilience in the Balearic Islands. The project includes a six-month eng...

Market News
Bullish
19 minutes ago
Nexans reports 10.1% revenue growth in 9M 2026, confirms 2026 outlook with strong performance in electrification segments.

Nexans reports 10.1% revenue growth in 9M 2026, confirms 2026 outlook with strong performance in electrification segments.

Nexans posted a 10.1% increase in revenue to €4.95 billion for the first nine months of 2026, driven by strong organic growth in its electrification segments PWR-Grid and PWR-Connect. The company successfully integrated Republic Wire in the US and co...

Company Fundamentals
Bullish
19 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App